Published in Gene Therapy Weekly, September 6th, 2007
Dr. Fons has been focused on business development relating to DNA vaccines and gene therapies for the past dozen years. His experience includes technology assessments, market and competitive analyses, intellectual property management, and defining and negotiating license and other corporate agreements. In the last three years, as Inovio's Executive Director, Corporate Development, Dr. Fons...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly